These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9738085)

  • 1. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.
    DiPaola RS; Zhang H; Lambert GH; Meeker R; Licitra E; Rafi MM; Zhu BT; Spaulding H; Goodin S; Toledano MB; Hait WN; Gallo MA
    N Engl J Med; 1998 Sep; 339(12):785-91. PubMed ID: 9738085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
    Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
    Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal composition PC-SPES for management of prostate cancer: identification of active principles.
    Sovak M; Seligson AL; Konas M; Hajduch M; Dolezal M; Machala M; Nagourney R
    J Natl Cancer Inst; 2002 Sep; 94(17):1275-81. PubMed ID: 12208892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PC-SPES in prostate cancer.
    Geliebter J; Tiwari R; Wu JM
    N Engl J Med; 1999 Feb; 340(7):567-8. PubMed ID: 10026051
    [No Abstract]   [Full Text] [Related]  

  • 5. Herbal supplement PC-Spes for prostate cancer.
    de Lemos ML
    Ann Pharmacother; 2002 May; 36(5):921-6. PubMed ID: 11978173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effect of PC-SPES on prostate growth and hepatic CYP3A expression in rats.
    Wadsworth T; Poonyagariyagorn H; Sullivan E; Koop D; Roselli CE
    J Pharmacol Exp Ther; 2003 Jul; 306(1):187-94. PubMed ID: 12676889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PC-SPES in prostate cancer.
    Small EJ
    N Engl J Med; 1999 Feb; 340(7):566-7; author reply 567-8. PubMed ID: 10026050
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.
    de la Taille A; Hayek OR; Burchardt M; Burchardt T; Katz AE
    J Altern Complement Med; 2000 Oct; 6(5):449-51. PubMed ID: 11059508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
    Hsieh TC; Wu JM
    Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
    Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
    J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PC-SPES and prostate cancer.
    Oh WK; Small EJ
    Urol Clin North Am; 2002 Feb; 29(1):59-66, viii. PubMed ID: 12109356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.
    Bonham M; Arnold H; Montgomery B; Nelson PS
    Cancer Res; 2002 Jul; 62(14):3920-4. PubMed ID: 12124319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.
    Small EJ; Frohlich MW; Bok R; Shinohara K; Grossfeld G; Rozenblat Z; Kelly WK; Corry M; Reese DM
    J Clin Oncol; 2000 Nov; 18(21):3595-603. PubMed ID: 11054432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease.
    Moyad MA; Pienta KJ; Montie JE
    Urology; 1999 Aug; 54(2):319-23; discussion 323-4. PubMed ID: 10443732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer.
    de la Taille A; Buttyan R; Hayek O; Bagiella E; Shabsigh A; Burchardt M; Burchardt T; Chopin DK; Katz AE
    J Urol; 2000 Oct; 164(4):1229-34. PubMed ID: 10992371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol.
    Guns ES; Goldenberg SL; Brown PN
    Can J Urol; 2002 Dec; 9(6):1684-8; discussion 1689. PubMed ID: 12517310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases.
    Oh WK; George DJ; Kantoff PW
    Cancer; 2002 Feb; 94(3):686-9. PubMed ID: 11857300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated intravascular coagulation and PC-SPES: a case report and literature review.
    Lock M; Loblaw DA; Choo R; Imrie K
    Can J Urol; 2001 Aug; 8(4):1326-9. PubMed ID: 11564276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients.
    de la Taille A; Hayek OR; Buttyan R; Bagiella E; Burchardt M; Katz AE
    BJU Int; 1999 Nov; 84(7):845-50. PubMed ID: 10532984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PC-SPES inhibits colon cancer growth in vitro and in vivo.
    Huerta S; Arteaga JR; Irwin RW; Ikezoe T; Heber D; Koeffler HP
    Cancer Res; 2002 Sep; 62(18):5204-9. PubMed ID: 12234985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.